FDA Submits Proposed Information Collection for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in response to a public health service guideline on infectious disease issues in xenotransplantation.